rs28641026

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_139027.6(ADAMTS13):​c.2910C>T​(p.Val970Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0369 in 1,613,948 control chromosomes in the GnomAD database, including 1,344 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.031 ( 104 hom., cov: 32)
Exomes 𝑓: 0.038 ( 1240 hom. )

Consequence

ADAMTS13
NM_139027.6 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -5.14

Publications

10 publications found
Variant links:
Genes affected
ADAMTS13 (HGNC:1366): (ADAM metallopeptidase with thrombospondin type 1 motif 13) This gene encodes a member of a family of proteins containing several distinct regions, including a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. The enzyme encoded by this gene specifically cleaves von Willebrand Factor (vWF). Defects in this gene are associated with thrombotic thrombocytopenic purpura. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
ADAMTS13 Gene-Disease associations (from GenCC):
  • congenital thrombotic thrombocytopenic purpura
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 9-133449831-C-T is Benign according to our data. Variant chr9-133449831-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262438.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-5.14 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0308 (4694/152198) while in subpopulation NFE AF = 0.0403 (2742/67996). AF 95% confidence interval is 0.0391. There are 104 homozygotes in GnomAd4. There are 2366 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 104 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADAMTS13NM_139027.6 linkc.2910C>T p.Val970Val synonymous_variant Exon 23 of 29 ENST00000355699.7 NP_620596.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADAMTS13ENST00000355699.7 linkc.2910C>T p.Val970Val synonymous_variant Exon 23 of 29 1 NM_139027.6 ENSP00000347927.2

Frequencies

GnomAD3 genomes
AF:
0.0309
AC:
4692
AN:
152080
Hom.:
104
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0117
Gnomad AMI
AF:
0.122
Gnomad AMR
AF:
0.0226
Gnomad ASJ
AF:
0.0248
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0188
Gnomad FIN
AF:
0.0723
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0403
Gnomad OTH
AF:
0.0283
GnomAD2 exomes
AF:
0.0313
AC:
7850
AN:
250634
AF XY:
0.0324
show subpopulations
Gnomad AFR exome
AF:
0.0100
Gnomad AMR exome
AF:
0.0150
Gnomad ASJ exome
AF:
0.0227
Gnomad EAS exome
AF:
0.000544
Gnomad FIN exome
AF:
0.0675
Gnomad NFE exome
AF:
0.0405
Gnomad OTH exome
AF:
0.0335
GnomAD4 exome
AF:
0.0376
AC:
54923
AN:
1461750
Hom.:
1240
Cov.:
32
AF XY:
0.0372
AC XY:
27065
AN XY:
727178
show subpopulations
African (AFR)
AF:
0.00980
AC:
328
AN:
33480
American (AMR)
AF:
0.0149
AC:
667
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.0222
AC:
581
AN:
26134
East Asian (EAS)
AF:
0.000327
AC:
13
AN:
39700
South Asian (SAS)
AF:
0.0229
AC:
1979
AN:
86252
European-Finnish (FIN)
AF:
0.0660
AC:
3520
AN:
53316
Middle Eastern (MID)
AF:
0.0333
AC:
192
AN:
5758
European-Non Finnish (NFE)
AF:
0.0411
AC:
45684
AN:
1112002
Other (OTH)
AF:
0.0324
AC:
1959
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
3265
6530
9796
13061
16326
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1656
3312
4968
6624
8280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0308
AC:
4694
AN:
152198
Hom.:
104
Cov.:
32
AF XY:
0.0318
AC XY:
2366
AN XY:
74400
show subpopulations
African (AFR)
AF:
0.0117
AC:
488
AN:
41542
American (AMR)
AF:
0.0226
AC:
345
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0248
AC:
86
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.0186
AC:
90
AN:
4826
European-Finnish (FIN)
AF:
0.0723
AC:
766
AN:
10588
Middle Eastern (MID)
AF:
0.0204
AC:
6
AN:
294
European-Non Finnish (NFE)
AF:
0.0403
AC:
2742
AN:
67996
Other (OTH)
AF:
0.0280
AC:
59
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
240
480
719
959
1199
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
62
124
186
248
310
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0311
Hom.:
50
Bravo
AF:
0.0258
Asia WGS
AF:
0.00924
AC:
32
AN:
3478
EpiCase
AF:
0.0379
EpiControl
AF:
0.0370

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 04, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 22768050) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Upshaw-Schulman syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
0.27
DANN
Benign
0.79
PhyloP100
-5.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28641026; hg19: chr9-136314952; API